SALLY BENYAHIA: Open Payments
NPI 1588626782 · KENNER, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,565 in 81 payments from 18 companies in 2025. Trend: 2023 $1,408 · 2024 $1,550 · 2025 $1,565
Food & beverage: $1,445Education: $120
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 16 | $247 |
| GENZYME CORPORATION | 13 | $246 |
| Regeneron Healthcare Solutions, Inc. | 6 | $183 |
| PFIZER INC. | 13 | $162 |
| LEO Pharma Inc. | 5 | $120 |
| Amgen Inc. | 5 | $108 |
| Janssen Biotech, Inc. | 3 | $64 |
| Galderma Laboratories, L.P. | 4 | $60 |
| Cipher Pharmaceuticals US LLC | 1 | $59 |
| Incyte Corporation | 2 | $56 |
Products named: DUPIXENT, Bimzelx, CIBINQO, OTEZLA, ADBRY, TREMFYA, NEMLUVIO, Natroba.
Industry payments across LA — which companies pay providers there.
